All cited findings remain pre-clinical or limited cosmetic-research data
Another study published in May 2025 from Sexual Medicine summarized "Glucagon-like peptide 1 analogue can be an alternative option for symptomatic massive obesity associated with testosterone deficiency." In plain English: GLP-1 meds (like Ozempic or Mounjaro) might be a good option for men with severe obesity who also have low testosterone
Neither interferes with the other's molecular target, receptor binding, or downstream signaling
Randomized studies have shown that chromium supplementation, often in combination with other compounds, can modestly improve markers of glycemic control
By targeting GLP-1, GIP, and glucagon receptors simultaneously, researchers are gaining new insights into metabolic biology and peptide engineering
10.1080/15257770.2011.623685 77 KennyE